Cerus Corporation
CERS
#7725
Rank
C$0.47 B
Marketcap
C$2.47
Share price
-2.73%
Change (1 day)
20.02%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.51 Million, an increase over its 2023 earnings that were of -C$40.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-37.94%
2024 -C$16.51 Million-58.95%
2023 -C$40.2 Million-20.74%
2022 -C$50.72 Million-25.7%
2021 -C$68.26 Million-11.99%
2020 -C$77.56 Million-14%
2019 -C$90.19 Million21.73%
2018 -C$74.09 Million-0.65%
2017 -C$74.57 Million-10.96%
2016 -C$83.75 Million4.24%
2015 -C$80.35 Million50.99%
2014 -C$53.22 Million-10.08%
2013 -C$59.18 Million184.13%
2012 -C$20.83 Million-7.91%
2011 -C$22.62 Million
2009 -C$31.95 Million-24.69%
2008 -C$42.42 Million-25.2%
2007 -C$56.71 Million330.54%
2006 -C$13.17 Million1.49%
2005 -C$12.98 Million-61.02%
2004 -C$33.3 Million
2002 -C$82.35 Million10.02%
2001 -C$74.85 Million34.25%
2000 -C$55.76 Million61.02%
1999 -C$34.63 Million-18.81%
1998 -C$42.65 Million93.08%
1997 -C$22.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$4.70 B-46,873.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.3 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.34 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.19 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA